(2E)-1-(3-bromophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 2g

[3-(3-nitrophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 2g

tert-Butyl 4-(hydroxymethyl)-1H-imidazole-1-carboxylate, 98%, 250mg

Quinoxaline, 5-(bromomethyl)-, 95%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((4-methoxybenzyl)selanyl)butanoic acid, 98%, 100mg

tert-Butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate, 95.0%, 10g

Palladium(II) iodide, 95.0%, 10g

(2-Methylpyridin-3-yl)methanamine dihydrochloride, 95.0%, 10g

(+/-)-Sulpiride>98.0%(HPLC)(T)5g

N-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]ethanamine hydrochloride, 95.0%, 5g

N8-Acetylspermidine dihydrochloride, ��98.0%, 1mg

5,6-Dimethoxybenzo[b]thiophene-2-carboxylic acid, 95%, 1g

2-Cyclopentyloxy-benzaldehyde, 95.0%, 10g